{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:40:00Z","timestamp":1784929200206,"version":"3.55.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Molecular Tumor Boards (MTBs) are a pillar of precision oncology, integrating results of extended molecular profiling into clinical care. Yet, their protocols are typically incomprehensible for patients. Systematic patient-facing communication has remained limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In the single-center study MyCODE, individually tailored lay-language MTB protocols were developed based on didactic and psychological principles and prospectively evaluated. Using questionnaires adapted and developed for this task, patients with cancer evaluated their individual protocols and overall experience. Treating physicians were surveyed separately.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty-three patients were enrolled, 33 (77%; 55% women; median age 65; patients with 10 different cancer entities) returned completed questionnaires. Of those, 82% shared the questionnaire with at least one additional person. Lay-language protocols were perceived as helpful (68% \u201cvery,\u201d 29% \u201crather\u201d), well-structured (71% \u201cvery,\u201d 29% \u201crather\u201d), and easily comprehensible (63% \u201cvery,\u201d 31% \u201crather\u201d) by most patients. 85% reported that the protocol improved their understanding of treatment decisions, and 94% perceived them as supportive even if the MTB failed to provide options for precision therapy. Additionally, 13 treating physicians received questionnaires, of which 9 were returned. Responding physicians rated the benefit for patients as high (44%) or very high (44%) and supportive (67%) or rather supportive (33%) for their personal work.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Providing patients with lay-language MTB protocols is feasible, accepted, and valued even in the absence of therapeutic options. The MyCODE approach seems to enable patient empowerment and to support patients and physicians in shared decision-making in precision oncology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/oncolo\/oyag119","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:32:49Z","timestamp":1774870369000},"source":"Crossref","is-referenced-by-count":1,"title":["<i>MyCODE<\/i>\n                    : a prospective evaluation of lay-language molecular tumor board protocols in precision oncology"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6725-9829","authenticated-orcid":false,"given":"Ina","family":"Pretzell","sequence":"first","affiliation":[{"name":"University Hospital Essen West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Fleischhauer","sequence":"additional","affiliation":[{"name":"University Hospital Essen West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilektra","family":"Mavroeidi","sequence":"additional","affiliation":[{"name":"University Hospital Essen West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]},{"name":"University Hospital Essen Department of Medical Oncology, West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]},{"name":"University Hospital Essen and University of Duisburg-Essen Bridge Institute of Experimental Tumor Therapy (BIT), West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Prasuhn","sequence":"additional","affiliation":[{"name":"University Hospital Essen Patient Advisory Board, West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Kaminski","sequence":"additional","affiliation":[{"name":"University Hospital Essen West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00eblle","family":"Bender","sequence":"additional","affiliation":[{"name":"University of Duisburg-Essen Social Psychology, Department of Human-Centered Computing and Cognitive Science, , Duisburg 47057,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Gr\u00fcnwald","sequence":"additional","affiliation":[{"name":"University Hospital Essen West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]},{"name":"University Hospital Essen Institute for Urologic Oncology, West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Holly","sequence":"additional","affiliation":[{"name":"University Hospital Essen Department of Gynecology and Obstetrics, West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"H\u00f6rbelt-Gr\u00fcnheidt","sequence":"additional","affiliation":[{"name":"University Hospital Essen Institute for Medical Education, Centre for Translational Neuro- and Behavioral Sciences (C-TNBS), , Essen 45147,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabea","family":"Pakull","sequence":"additional","affiliation":[{"name":"University Hospital Essen Institute for Transfusion Medicine, , Essen 45147,","place":["Germany"]},{"name":"University of Applied Arts and Science Dortmund Department of Computer Science, , Dortmund 44227,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Rosery","sequence":"additional","affiliation":[{"name":"University Hospital Essen West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]},{"name":"University Hospital Essen Department of Medical Oncology, West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Sch\u00fcrmann","sequence":"additional","affiliation":[{"name":"University Hospital Essen West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]},{"name":"University Hospital Essen Department of Medical Oncology, West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]},{"name":"University Hospital Essen and University of Duisburg-Essen Bridge Institute of Experimental Tumor Therapy (BIT), West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5949-8120","authenticated-orcid":false,"given":"Sebastian","family":"Bauer","sequence":"additional","affiliation":[{"name":"University Hospital Essen West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]},{"name":"University Hospital Essen Department of Medical Oncology, West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]},{"name":"NCT West National Center for Tumor Diseases (NCT), , Essen 45147,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens T","family":"Siveke","sequence":"additional","affiliation":[{"name":"University Hospital Essen West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]},{"name":"University Hospital Essen Department of Medical Oncology, West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]},{"name":"University Hospital Essen and University of Duisburg-Essen Bridge Institute of Experimental Tumor Therapy (BIT), West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]},{"name":"German Cancer Consortium (DKTK), Partner Site Essen, a partnership between German Cancer Research Center (DKFZ) and University Hospital Essen Division of Solid Tumor Translational Oncology, , Essen 45147,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Wiesweg","sequence":"additional","affiliation":[{"name":"University Hospital Essen West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]},{"name":"University Hospital Essen Department of Medical Oncology, West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]},{"name":"NCT West National Center for Tumor Diseases (NCT), , Essen 45147,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Zimmer","sequence":"additional","affiliation":[{"name":"University Hospital Essen West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]},{"name":"University Hospital Essen Department of Dermatology, West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3524-7858","authenticated-orcid":false,"given":"Dirk","family":"Schadendorf","sequence":"additional","affiliation":[{"name":"University Hospital Essen West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]},{"name":"NCT West National Center for Tumor Diseases (NCT), , Essen 45147,","place":["Germany"]},{"name":"University Hospital Essen Department of Dermatology, West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2166-3394","authenticated-orcid":false,"given":"Martin","family":"Schuler","sequence":"additional","affiliation":[{"name":"University Hospital Essen West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]},{"name":"University Hospital Essen Department of Medical Oncology, West German Cancer Center (WTZ), , Essen 45147,","place":["Germany"]},{"name":"NCT West National Center for Tumor Diseases (NCT), , Essen 45147,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Benson","sequence":"additional","affiliation":[{"name":"University Hospital Essen Institute for Medical Education, Centre for Translational Neuro- and Behavioral Sciences (C-TNBS), , Essen 45147,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"2026042618472468400_oyag119-B1","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41571-023-00824-4","article-title":"Molecular tumour boards\u2014current and future considerations for precision oncology","volume":"20","author":"Tsimberidou","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"2026042618472468400_oyag119-B2","doi-asserted-by":"publisher","first-page":"e000398","DOI":"10.1136\/esmoopen-2018-000398","article-title":"Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer","volume":"3","author":"Rolfo","year":"2018","journal-title":"ESMO Open"},{"key":"2026042618472468400_oyag119-B3","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.trecan.2020.05.008","article-title":"Molecular tumor boards in clinical practice","volume":"6","author":"Luchini","year":"2020","journal-title":"Trends Cancer"},{"key":"2026042618472468400_oyag119-B4","doi-asserted-by":"publisher","first-page":"115331","DOI":"10.1016\/j.ejca.2025.115331","article-title":"Precision oncology\u2014guideline of the Austrian, German and Swiss societies for Hematology and Medical Oncology","volume":"220","author":"Rieke","year":"2025","journal-title":"Eur J Cancer"},{"key":"2026042618472468400_oyag119-B5","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.annonc.2025.02.009","article-title":"ESMO precision oncology working group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice","volume":"36","author":"Westphalen","year":"2025","journal-title":"Ann Oncol"},{"key":"2026042618472468400_oyag119-B6","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/s41591-023-02354-z","article-title":"The German network for personalized medicine to enhance patient care and translational research","volume":"29","author":"Illert","year":"2023","journal-title":"Nat Med"},{"key":"2026042618472468400_oyag119-B7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00761-020-00725-6","article-title":"Das molekulare tumorboard: ethische herausforderungen","volume":"26","author":"Schickhardt","year":"2020","journal-title":"Onkologe"},{"key":"2026042618472468400_oyag119-B8","doi-asserted-by":"publisher","first-page":"e6913","DOI":"10.1002\/cam4.6913","article-title":"Understanding communication between patients and healthcare professionals regarding comprehensive biomarker testing in precision oncology: a scoping review","volume":"13","author":"Pichler","year":"2024","journal-title":"Cancer Med"},{"key":"2026042618472468400_oyag119-B9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-157-7-201210020-00002","article-title":"Inviting patients to read their doctors\u2019 notes: a quasi-experimental study and a look ahead","volume":"157","author":"Delbanco","year":"2012","journal-title":"Ann Intern Med"},{"key":"2026042618472468400_oyag119-B10","doi-asserted-by":"publisher","first-page":"e13876","DOI":"10.2196\/13876","article-title":"OpenNotes after 7 years: Patient experiences with ongoing access to their clinicians\u2019 outpatient visit notes","volume":"21","author":"Walker","year":"2019","journal-title":"J Med Internet Res"},{"key":"2026042618472468400_oyag119-B11","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-72192-6","volume-title":"Der Placebo-Effekt. Wissenswertes F\u00fcr Gesundheitsberufe","author":"Peters","year":"2025"},{"key":"2026042618472468400_oyag119-B12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00115-020-00963-4","article-title":"Nocebo, aufkl\u00e4rung und Arzt-Patienten-Kommunikation [nocebo, informed consent and doctor-patient communication] [in German]","volume":"91","author":"Hansen","year":"2020","journal-title":"Nervenarzt"},{"key":"2026042618472468400_oyag119-B13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/jama.2025.6261","article-title":"Improving patients\u2019 treatment expectations","volume":"334","author":"Laferton","year":"2025","journal-title":"JAMA."},{"key":"2026042618472468400_oyag119-B14","first-page":"19","volume-title":"Sich Verst\u00e4ndlich Ausdr\u00fccken","author":"Langer","year":"2011","edition":"9. Aufl"},{"key":"2026042618472468400_oyag119-B15","author":"European Medicines Agency","year":"2021"},{"key":"2026042618472468400_oyag119-B16","doi-asserted-by":"publisher","first-page":"S183","DOI":"10.1055\/a-2130-2374","article-title":"Associations of an easy-to-understand patient letter on the health literacy of patients after discharge from hospital: results of a randomized controlled intervention study","volume":"85","author":"Hoffmann","year":"2023","journal-title":"Gesundheitswesen"},{"key":"2026042618472468400_oyag119-B17","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1186\/s12913-025-13464-4","article-title":"Evaluating the impact of easy-to-understand patient letters after discharge on patients\u2019 health literacy: a randomized controlled study","volume":"25","author":"Riemenschneider","year":"2025","journal-title":"BMC Health Serv Res"},{"key":"2026042618472468400_oyag119-B18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/pon.1955","article-title":"Patients\u2019 perception of the usefulness of a question prompt sheet for advanced cancer patients when deciding the initial treatment: a randomized, controlled trial","volume":"21","author":"Shirai","year":"2012","journal-title":"Psychooncology"},{"key":"2026042618472468400_oyag119-B19","doi-asserted-by":"publisher","first-page":"102597","DOI":"10.1016\/j.ejon.2024.102597","article-title":"Evaluation of patient satisfaction of receiving systemic anti-cancer therapy prescribed by nurse non-medical prescribers","volume":"70","author":"McCauley","year":"2024","journal-title":"Eur J Oncol Nurs"},{"key":"2026042618472468400_oyag119-B20","doi-asserted-by":"publisher","first-page":"e13705","DOI":"10.1111\/ecc.13705","article-title":"Patients\u2019 experiences with cancer care in Switzerland: Results of a multicentre cross-sectional survey","volume":"31","author":"Arditi","year":"2022","journal-title":"Eur J Cancer Care (Engl.)"},{"key":"2026042618472468400_oyag119-B21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1634\/theoncologist.2013-0374","article-title":"Self-reported financial burden and satisfaction with care among patients with cancer","volume":"19","author":"Chino","year":"2014","journal-title":"Oncologist"},{"key":"2026042618472468400_oyag119-B22","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00520-007-0362-4","article-title":"Patients satisfaction in outpatient cancer care: a prospective survey using the PASQOC questionnaire","volume":"16","author":"Kleeberg","year":"2008","journal-title":"Support Care Cancer"},{"key":"2026042618472468400_oyag119-B23","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1089\/jicm.2024.0185","article-title":"Survey of oncology patients\u2018perceptions on integrative medicine and awareness of resources at an academic cancer center","volume":"31","author":"Chen","year":"2025","journal-title":"J Integr Complement Med"},{"key":"2026042618472468400_oyag119-B24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/pon.5282","article-title":"Cancer patients\u2019 expectations when undergoing extensive molecular diagnostics-A qualitative study","volume":"29","author":"Rohrmoser","year":"2020","journal-title":"Psychooncology"},{"key":"2026042618472468400_oyag119-B25","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1370\/afm.1301","article-title":"Shared mind: communication, decision making, and autonomy in serious illness","volume":"9","author":"Epstein","year":"2011","journal-title":"Ann Fam Med"},{"key":"2026042618472468400_oyag119-B26","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3238\/arztebl.2012.0459","article-title":"Nocebo phenomena in medicine: their relevance in everyday clinical practice","volume":"109","author":"H\u00e4user","year":"2012","journal-title":"Dtsch Arztebl Int"},{"key":"2026042618472468400_oyag119-B27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fphar.2019.00077","article-title":"Nocebo effects and negative suggestions in daily clinical practice: forms, impact and approaches to avoid them","volume":"10","author":"Hansen","year":"2019","journal-title":"Front Pharmacol"},{"key":"2026042618472468400_oyag119-B28","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","article-title":"Shared decision making: a model for clinical practice","volume":"27","author":"Elwyn","year":"2012","journal-title":"J Gen Intern Med"},{"key":"2026042618472468400_oyag119-B29","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.pec.2015.06.022","article-title":"Shared decision making: really putting patients at the Centre of healthcare","volume":"98","author":"Stiggelbout","year":"2015","journal-title":"Patient Educ Couns"},{"key":"2026042618472468400_oyag119-B30","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/jama.288.6.756","article-title":"Physician gender effects in medical communication: a meta-analytic review","volume":"288","author":"Roter","year":"2002","journal-title":"JAMA"},{"key":"2026042618472468400_oyag119-B31","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1186\/s12889-016-3810-6","article-title":"Health literacy among different age groups in Germany: results of a cross-sectional survey","volume":"16","author":"Berens","year":"2016","journal-title":"BMC Public Health"},{"key":"2026042618472468400_oyag119-B32","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1186\/s12913-024-11563-2","article-title":"Awareness, use and perception of patient versions of clinical practice guidelines\u2014a national cross-sectional survey among patients with a cancer diagnosis and healthcare providers","volume":"24","author":"Bl\u00f6dt","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"2026042618472468400_oyag119-B33","doi-asserted-by":"publisher","first-page":"e201753","DOI":"10.1001\/jamanetworkopen.2020.1753","article-title":"The views and experiences of clinicians sharing medical record notes with patients","volume":"3","author":"DesRoches","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026042618472468400_oyag119-B34","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1177\/0272989X16644427","article-title":"Dissemination of clinical practice guidelines: a content analysis of patient versions","volume":"36","author":"Santesso","year":"2016","journal-title":"Med Decis Making"},{"key":"2026042618472468400_oyag119-B35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jclinepi.2023.07.005","article-title":"Heterogeneous methodology in the development of patient versions of clinical practice guidelines: a scoping review","volume":"161","author":"Meyer","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"2026042618472468400_oyag119-B36","first-page":"2785","author":"Li"},{"key":"2026042618472468400_oyag119-B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/3589955","article-title":"Paper plain : Making medical research papers approachable to healthcare consumers with natural language processing","volume":"30","author":"August","year":"2023","journal-title":"ACM Trans Comput-Hum Interact"},{"key":"2026042618472468400_oyag119-B38","first-page":"124","author":"Dada"},{"key":"2026042618472468400_oyag119-B39","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1200\/JOP.19.00274","article-title":"Understanding patients\u2019 attitudes toward cancer multidisciplinary meetings: a mixed methods study","volume":"16","author":"Devitt","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"2026042618472468400_oyag119-B40","doi-asserted-by":"publisher","first-page":"e0139921","DOI":"10.1371\/journal.pone.0139921","article-title":"In absentia: an exploratory study of how patients are considered in multidisciplinary cancer team meetings","volume":"10","author":"Hahlweg","year":"2015","journal-title":"PLoS One"},{"key":"2026042618472468400_oyag119-B41","doi-asserted-by":"publisher","first-page":"100860","DOI":"10.1016\/j.currproblcancer.2022.100860","article-title":"Patient attendance at molecular tumor board: a new means of shared decision making?","volume":"46","author":"Cannon","year":"2022","journal-title":"Curr Probl Cancer"},{"key":"2026042618472468400_oyag119-B42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.breast.2018.12.012","article-title":"How do breast cancer patients experience multidisciplinary tumor conferences? A description from the patient perspective","volume":"44","author":"Diekmann","year":"2019","journal-title":"Breast"},{"key":"2026042618472468400_oyag119-B43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.18653\/v1\/2025.cl4health-1.15","volume-title":"Proceedings of the Second Workshop on Patient-Oriented Language Processing (CL4Health)","author":"Pakull","year":"2025"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/advance-article-pdf\/doi\/10.1093\/oncolo\/oyag119\/67695400\/oyag119.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/31\/5\/oyag119\/68103115\/oyag119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/31\/5\/oyag119\/68103115\/oyag119.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T22:47:30Z","timestamp":1777243650000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/doi\/10.1093\/oncolo\/oyag119\/8566421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,4,10]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyag119","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,3,31]]},"article-number":"oyag119"}}